| Trial name or title | Varenicline for smoking cessation/reduction in patients with bipolar disorder |
| Methods | Randomised placebo‐controlled quadruple‐blind trial |
| Participants | 30 adult smokers with bipolar disorder |
| Interventions | Varenicline flexible dosing (0.5 to 2.0 mg/day) vs placebo for 10 weeks. All get group CBT. |
| Outcomes | Smoking cessation and safety at 10 weeks |
| Starting date | November 2009 |
| Contact information | Tony George |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.